Item 8.01 Other Events

On January 19, 2021, Acorda Therapeutics, Inc. (the "Company") received a letter from The Nasdaq Stock Market, LLC notifying the Company that it had regained compliance with Listing Rule 5450(a)(1), which requires that listed securities maintain a minimum closing bid price of at least $1.00 per share (the "Minimum Bid Requirement"). The Company regained compliance with the Minimum Bid Requirement based on the closing bid price of the Company's common stock on the Nasdaq Global Select Market between January 4, 2021 and January 15, 2021. The Company had previously been notified of its non-compliance with the Minimum Bid Requirement on July 23, 2020, as described in the Company's Current Report on Form 8-K filed on July 24, 2020.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses